Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 10086021 was granted and assigned to 4D Pharma PLC on October, 2018 by the United States Patent and Trademark Office. | 10086021 | October 2, 2018 | |||||||
Patent 10086022 was granted and assigned to 4D Pharma PLC on October, 2018 by the United States Patent and Trademark Office. | 10086022 | October 2, 2018 | |||||||
Patent 10086020 was granted and assigned to 4D Pharma PLC on October, 2018 by the United States Patent and Trademark Office. | 10086020 | October 2, 2018 | |||||||
Patent 10080772 was granted and assigned to 4D Pharma PLC on September, 2018 by the United States Patent and Trademark Office. | 10080772 | September 25, 2018 | |||||||
Patent 10086023 was granted and assigned to 4D Pharma PLC on October, 2018 by the United States Patent and Trademark Office. | 10086023 | October 2, 2018 | |||||||
Patent 10898526 was granted and assigned to 4D Pharma PLC on January, 2021 by the United States Patent and Trademark Office. | 10898526 | January 26, 2021 | |||||||
Patent 10967010 was granted and assigned to 4D Pharma PLC on April, 2021 by the United States Patent and Trademark Office. | 10967010 | April 6, 2021 | |||||||
Patent 10960031 was granted and assigned to 4D Pharma PLC on March, 2021 by the United States Patent and Trademark Office. | 10960031 | March 30, 2021 | |||||||
Patent 10485830 was granted and assigned to 4D Pharma PLC on November, 2019 by the United States Patent and Trademark Office. | 10485830 | November 26, 2019 | |||||||
Patent 11224620 was granted and assigned to 4D Pharma PLC on January, 2022 by the United States Patent and Trademark Office. | 11224620 | January 18, 2022 |